Galderma stock advances as shareholder and board decisions remain in focus
Published on 11/11/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSShareholder Decisions Shape Galderma
- Shareholders approved a gross dividend of CHF 0.35 per dividend-bearing share.
- The April meeting added one independent director and two L'Oréal representatives to the board.
- A virtual extraordinary meeting on December 3 will address further board changes.
Since the latest report on Wednesday, November 11, Galderma stock has moved from 207.00 euros at 12:20 CET to 210.50 euros at 17:17 CET, a gain of 1.69 percent. Galderma stock traded at 210.50 euros on Lang & Schwarz at 17:17 CET on Wednesday, November 11, 2026.
The corporate backdrop remains the Annual General Meeting held in Zug on April 22, 2026. According to Galderma, shareholders approved all proposals submitted by the Board of Directors.
Dividend Decision Supports Shareholder Returns
The resolutions included a gross dividend of CHF 0.35 per dividend-bearing share. Galderma said the payment would be distributed from reserves from capital contributions under the applicable Swiss tax rules.
The decision provides a direct shareholder-return element, but it does not change the company's dermatology portfolio or financial outlook. Investors therefore have to weigh the payout alongside operating performance and the next governance steps.
Board Composition Adds New Representation
Harry Kirsch was elected as an independent board member. Samuel du Retail and Delphine Viguier-Hovasse, both L'Oréal representatives, joined as non-independent members.
Thomas Ebeling, Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Flemming Ornskov were re-elected. The result combines continuity with additional representation linked to L'Oréal.
December Vote Sets Next Milestone
The AGM also approved Galderma's 2025 Annual Financial Statements, Non-Financial Report and Compensation Report. The company said detailed voting results and the official minutes would be published on its investor-relations website within two weeks of the meeting.
Investors will next focus on the virtual extraordinary general meeting scheduled for Thursday, December 3, 2026, at 14:00 CET. The meeting is expected to address proposed board appointments and related governance changes.
Galderma Group AG
- Company: Galderma Group AG
- ISIN: CH1335392721
- Ticker: GALD
- Home exchange: SIX Swiss Exchange
- Lang & Schwarz quote: 210.50 euros at 17:17 CET on Wednesday, November 11, 2026
- Approved dividend: CHF 0.35 gross per dividend-bearing share
- Next event: Extraordinary General Meeting on December 3, 2026, at 14:00 CET
Swiss equities continue to trade against the broader backdrop of the SMI market.
